Anakinra for the management of resistant idiopathic recurrent pericarditis. Initial experience in 10 adult cases

Ann Rheum Dis. 2014 Dec;73(12):2215-7. doi: 10.1136/annrheumdis-2014-205990. Epub 2014 Aug 27.

Authors

George Lazaros¹, Panagiotis Vasileiou¹, Christos Koutsianas², Katerina Antonatou², Christodoulos Stefanadis¹, Dimitrios Pectasides², Dimitrios Vassilopoulos²

Affiliations

¹ 1st Department of Cardiology, University of Athens Medical School, Hippokration General Hospital, Athens, Greece.
² 2nd Department of Medicine and Laboratory, Clinical Immunology and Rheumatology Unit, University of Athens Medical School, Hippokration General Hospital, Athens, Greece.

PMID: 25165036
DOI: 10.1136/annrheumdis-2014-205990

No abstract available

Keywords: Autoimmune Diseases; Corticosteroids; Inflammation; NSAIDs.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Antirheumatic Agents / therapeutic use*
Cohort Studies
Drug Resistance
Female
Humans
Interleukin 1 Receptor Antagonist Protein / therapeutic use*
Male
Middle Aged
Pericarditis / drug therapy*
Pericarditis / immunology
Recurrence
Treatment Outcome
Young Adult

Substances

Antirheumatic Agents
Interleukin 1 Receptor Antagonist Protein